95 related articles for article (PubMed ID: 21498692)
1. HMGA2 and p14Arf: major roles in cellular senescence of fibroids and therapeutic implications.
Markowski DN; Helmke BM; Belge G; Nimzyk R; Bartnitzke S; Deichert U; Bullerdiek J
Anticancer Res; 2011 Mar; 31(3):753-61. PubMed ID: 21498692
[TBL] [Abstract][Full Text] [Related]
2. p14Arf acts as an antagonist of HMGA2 in senescence of mesenchymal stem cells-implications for benign tumorigenesis.
Markowski DN; Winter N; Meyer F; von Ahsen I; Wenk H; Nolte I; Bullerdiek J
Genes Chromosomes Cancer; 2011 Jul; 50(7):489-98. PubMed ID: 21456046
[TBL] [Abstract][Full Text] [Related]
3. Fibroid explants reveal a higher sensitivity against MDM2-inhibitor nutlin-3 than matching myometrium.
Markowski DN; Helmke BM; Radtke A; Froeb J; Belge G; Bartnitzke S; Wosniok W; Czybulka-Jachertz I; Deichert U; Bullerdiek J
BMC Womens Health; 2012 Jan; 12():2. PubMed ID: 22233735
[TBL] [Abstract][Full Text] [Related]
4. Activation of p53 by Nutlin-3a, an antagonist of MDM2, induces apoptosis and cellular senescence in adult T-cell leukemia cells.
Hasegawa H; Yamada Y; Iha H; Tsukasaki K; Nagai K; Atogami S; Sugahara K; Tsuruda K; Ishizaki A; Kamihira S
Leukemia; 2009 Nov; 23(11):2090-101. PubMed ID: 19710698
[TBL] [Abstract][Full Text] [Related]
5. HMGA2 and the p19Arf-TP53-CDKN1A axis: a delicate balance in the growth of uterine leiomyomas.
Markowski DN; von Ahsen I; Nezhad MH; Wosniok W; Helmke BM; Bullerdiek J
Genes Chromosomes Cancer; 2010 Aug; 49(8):661-8. PubMed ID: 20544840
[TBL] [Abstract][Full Text] [Related]
6. MDM2 inhibitor nutlin-3a induces apoptosis and senescence in cutaneous T-cell lymphoma: role of p53.
Manfé V; Biskup E; Johansen P; Kamstrup MR; Krejsgaard TF; Morling N; Wulf HC; Gniadecki R
J Invest Dermatol; 2012 May; 132(5):1487-96. PubMed ID: 22377766
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of AKT induces cellular senescence in uterine leiomyoma.
Xu X; Lu Z; Qiang W; Vidimar V; Kong B; Kim JJ; Wei JJ
Endocrinology; 2014 Apr; 155(4):1510-9. PubMed ID: 24476133
[TBL] [Abstract][Full Text] [Related]
8. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
[TBL] [Abstract][Full Text] [Related]
9. Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis.
Dreidax D; Gogolin S; Schroeder C; Muth D; Brueckner LM; Hess EM; Zapatka M; Theißen J; Fischer M; Ehemann V; Schwab M; Savelyeva L; Westermann F
Hum Mol Genet; 2013 May; 22(9):1735-45. PubMed ID: 23343716
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of senescent cell formation and retention revealed by p14ARF induction in the epidermis.
Tokarsky-Amiel R; Azazmeh N; Helman A; Stein Y; Hassan A; Maly A; Ben-Porath I
Cancer Res; 2013 May; 73(9):2829-39. PubMed ID: 23423975
[TBL] [Abstract][Full Text] [Related]
11. Azidothymidine and cisplatin increase p14ARF expression in OVCAR-3 ovarian cancer cell line.
Vaskivuo L; Rysä J; Koivuperä J; Myllynen P; Vaskivuo T; Chvalova K; Serpi R; Savolainen ER; Puistola U; Vähäkangas K
Toxicol Appl Pharmacol; 2006 Oct; 216(1):89-97. PubMed ID: 16797627
[TBL] [Abstract][Full Text] [Related]
12. p53-induced apoptosis occurs in the absence of p14(ARF) in malignant pleural mesothelioma.
Hopkins-Donaldson S; Belyanskaya LL; Simões-Wüst AP; Sigrist B; Kurtz S; Zangemeister-Wittke U; Stahel R
Neoplasia; 2006 Jul; 8(7):551-9. PubMed ID: 16867217
[TBL] [Abstract][Full Text] [Related]
13. Induction of p53-dependent senescence by the MDM2 antagonist nutlin-3a in mouse cells of fibroblast origin.
Efeyan A; Ortega-Molina A; Velasco-Miguel S; Herranz D; Vassilev LT; Serrano M
Cancer Res; 2007 Aug; 67(15):7350-7. PubMed ID: 17671205
[TBL] [Abstract][Full Text] [Related]
14. ARF promotes accumulation of retinoblastoma protein through inhibition of MDM2.
Chang DL; Qiu W; Ying H; Zhang Y; Chen CY; Xiao ZX
Oncogene; 2007 Jul; 26(32):4627-34. PubMed ID: 17297463
[TBL] [Abstract][Full Text] [Related]
15. Cell culture and senescence in uterine fibroids.
Markowski DN; Bartnitzke S; Belge G; Drieschner N; Helmke BM; Bullerdiek J
Cancer Genet Cytogenet; 2010 Oct; 202(1):53-7. PubMed ID: 20804922
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma.
Peng Y; Laser J; Shi G; Mittal K; Melamed J; Lee P; Wei JJ
Mol Cancer Res; 2008 Apr; 6(4):663-73. PubMed ID: 18403645
[TBL] [Abstract][Full Text] [Related]
17. HMGA proteins regulate the expression of FGF2 in uterine fibroids.
Helmke BM; Markowski DN; Müller MH; Sommer A; Müller J; Möller C; Bullerdiek J
Mol Hum Reprod; 2011 Feb; 17(2):135-42. PubMed ID: 20926602
[TBL] [Abstract][Full Text] [Related]
18. Cellular senescence in usual type uterine leiomyoma.
Laser J; Lee P; Wei JJ
Fertil Steril; 2010 Apr; 93(6):2020-6. PubMed ID: 19217096
[TBL] [Abstract][Full Text] [Related]
19. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas.
Kumamoto H; Izutsu T; Ohki K; Takahashi N; Ooya K
J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490
[TBL] [Abstract][Full Text] [Related]
20. Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma.
Van Maerken T; Speleman F; Vermeulen J; Lambertz I; De Clercq S; De Smet E; Yigit N; Coppens V; Philippé J; De Paepe A; Marine JC; Vandesompele J
Cancer Res; 2006 Oct; 66(19):9646-55. PubMed ID: 17018622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
